Victoria Baltrus - Dec 1, 2023 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
Chief Accounting Officer
Signature
/s/ Melissa Curtin, Attorney-in-fact
Stock symbol
OSCR
Transactions as of
Dec 1, 2023
Transactions value $
-$42,267
Form type
4
Date filed
12/5/2023, 04:21 PM
Previous filing
Sep 6, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +4.12K +8.52% 52.5K Dec 1, 2023 Direct F1
transaction OSCR Class A Common Stock Options Exercise +4.81K +9.16% 57.3K Dec 1, 2023 Direct F1
transaction OSCR Class A Common Stock Options Exercise +7.5K +13.08% 64.8K Dec 1, 2023 Direct F1
transaction OSCR Class A Common Stock Sale -$42.3K -5.07K -7.82% $8.34 59.7K Dec 4, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Options Exercise $0 -4.12K -16.67% $0.00 20.6K Dec 1, 2023 Class A Common Stock 4.12K Direct F1, F4
transaction OSCR Restricted Stock Units Options Exercise $0 -4.81K -12.5% $0.00 33.7K Dec 1, 2023 Class A Common Stock 4.81K Direct F1, F5
transaction OSCR Restricted Stock Units Options Exercise $0 -7.5K -10% $0.00 67.5K Dec 1, 2023 Class A Common Stock 7.5K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2022.
F5 The restricted stock units vested with respect to 25% of the shares on September 1, 2022, and will vest with respect to the remaining shares in 12 equal quarterly installments thereafter.
F6 The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2023.